AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA for work on biopharmaceuticals; and Mölndal in Sweden, for research on traditional chemical drugs. Read More
AstraZeneca said on Monday that the company plans to apply for emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine in the first half of April. ...
AstraZeneca's Covid-19 vaccine showed 79 per cent efficacy against symptomatic disease and 100 per cent efficacy against severe disease and hospitalisation in a new, US-based clinical trial, the company said Monday. ...
Taiwan premier Su Tseng-chang and the Minister of Health and Welfare Chen Shih-Chung received their first shots of AstraZeneca COVID-19 vaccine on Monday as the country began administering the vaccines against coronavirus. ...
Canberra, March 22 Australia's medical regulator on Monday approved the domestically-produced AstraZeneca coronavirus vaccine. The Therapeutic Goods Administration ... ...